# Peter Menziuso Named EVP and President, BD Interventional
Canonical URL: https://biopharmsignal.com/news/BDX/peter-menziuso-named-evp-and-president-bd-interventional
Ticker: BDX
Company: Becton Dickinson
Source: Becton Dickinson
Published: 2026-05-18 10:50 EST
Original Source URL: https://investors.bd.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-21 10:50 EST — [BD Delivers Kidney Stone Care for Urology Teams with the Elyra™ Thulium Fiber Laser System](https://biopharmsignal.com/news/BDX/bd-delivers-kidney-stone-care-for-urology-teams-with-the-elyratm-thulium-fiber-laser-system) — Source: Becton Dickinson
- 2026-05-18 10:50 EST — [Peter Menziuso Named EVP and President, BD Interventional](https://biopharmsignal.com/news/BDX/peter-menziuso-named-evp-and-president-bd-interventional) — Source: Becton Dickinson
- 2026-05-07 10:31 EST — [BD Appoints Vitor Roque Chief Financial Officer](https://biopharmsignal.com/news/BDX/bd-appoints-vitor-roque-chief-financial-officer) — Source: Becton Dickinson
- 2026-05-07 10:30 EST — [BD Reports Second Quarter Fiscal 2026 Financial Results](https://biopharmsignal.com/news/BDX/bd-reports-second-quarter-fiscal-2026-financial-results) — Source: Becton Dickinson
- 2026-05-05 10:50 EST — [BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI](https://biopharmsignal.com/news/BDX/bd-and-wellstar-advance-patient-care-and-safety-with-medication-management-powered-by-ai) — Source: Becton Dickinson
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)